On March 19, 2018, the FDA will hold a 1-day public workshop on “Utilizing Innovative Statistical Methods and Trial Designs in Rare Disease Settings.”  The purpose of the workshop is to bring together rare disease stakeholders to discuss the challenges associated with the development and regulatory decision-making for rare disease treatments. The workshop will be held in Silver Spring, MD, and you may register to view a live webcast of the meeting if you are unable to attend in person.  Register at https://healthpolicy.duke.edu/events/innovative-tools-and-statistical-methods-treatment-development-rare-disease-settings (Federal Register)